• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医疗保险处方药部分对医疗保险-医疗补助双重资格受益人的处方使用和支出的影响。

Impact of Medicare Part D on Medicare-Medicaid dual-eligible beneficiaries' prescription utilization and expenditures.

机构信息

Section of General Internal Medicine, Department of Medicine, and Center for Health and the Social Sciences, University of Chicago, IL, USA.

出版信息

Health Serv Res. 2010 Feb;45(1):133-51. doi: 10.1111/j.1475-6773.2009.01065.x. Epub 2009 Dec 4.

DOI:10.1111/j.1475-6773.2009.01065.x
PMID:20002765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2813441/
Abstract

OBJECTIVE

To examine the effect of Part D on 65-78-year-old noninstitutionalized dual eligibles' prescription utilization and expenditures.

DATA SOURCE

Random sample of unique pharmacy customers of a national retail pharmacy chain who filled at least one prescription during both 2005 and 2006. For each subject, we obtained claims data for every prescription filled between January 1, 2005, and April 31, 2007.

STUDY DESIGN

Generalized estimating equations were used to examine the experience of a "treatment" group (dual eligibles between 65 and 78 years on January 1, 2005) with that of a "control" group (near-elderly patients with Medicaid coverage between 60 and 63 years on January 1, 2005) during the first 18 months after Part D implementation.

PRINCIPAL FINDINGS

Expenditures for the treatment and control groups tracked each other closely in the pre-Part D period. Immediately following the implementation of Part D, expenditures for both groups decreased and then leveled off. There were no significant changes in trends in the dual eligibles' out-of-pocket expenditures, total monthly expenditures, pill-days, or total number of prescriptions due to Part D.

CONCLUSIONS

We find no evidence that Part D adversely affected pharmaceutical utilization or out-of-pocket expenditures of dual eligibles during the transition period, nor during the 16 months subsequent to Part D implementation.

摘要

目的

考察医疗保险处方药补贴计划(Part D)对 65-78 岁、非住院的双重资格受益人的处方使用和支出的影响。

数据来源

全国零售连锁药店的独特药房顾客的随机抽样,这些顾客在 2005 年和 2006 年期间至少有一次处方。对于每个受试者,我们获得了在 2005 年 1 月 1 日至 2007 年 4 月 31 日期间填写的每一张处方的理赔数据。

研究设计

使用广义估计方程来研究“治疗”组(2005 年 1 月 1 日年龄在 65-78 岁之间的双重资格受益者)与“对照”组(2005 年 1 月 1 日年龄在 60-63 岁之间、有医疗补助覆盖的接近老年患者)在 Part D 实施后的前 18 个月内的经历。

主要发现

在 Part D 实施之前,治疗组和对照组的支出密切相关。在 Part D 实施后,两组的支出立即下降,然后趋于平稳。由于 Part D,双重资格受益人的自付支出、总月支出、用药天数或总处方数量都没有明显的变化趋势。

结论

我们没有发现证据表明 Part D 在过渡期间或 Part D 实施后的 16 个月内对双重资格受益人的药物利用或自付支出产生了不利影响。

相似文献

1
Impact of Medicare Part D on Medicare-Medicaid dual-eligible beneficiaries' prescription utilization and expenditures.医疗保险处方药部分对医疗保险-医疗补助双重资格受益人的处方使用和支出的影响。
Health Serv Res. 2010 Feb;45(1):133-51. doi: 10.1111/j.1475-6773.2009.01065.x. Epub 2009 Dec 4.
2
The effect of the Medicare Part D prescription benefit on drug utilization and expenditures.医疗保险D部分处方药福利对药物使用和支出的影响。
Ann Intern Med. 2008 Feb 5;148(3):169-77. doi: 10.7326/0003-4819-148-3-200802050-00200. Epub 2008 Jan 7.
3
Associations Between Medicare Part D and Out-of-Pocket Spending, HIV Viral Load, Adherence, and ADAP Use in Dual Eligibles With HIV.医疗保险D部分与HIV双重资格受益人的自付费用、HIV病毒载量、依从性及艾滋病药物援助项目使用情况之间的关联
Med Care. 2018 Jan;56(1):47-53. doi: 10.1097/MLR.0000000000000843.
4
Effects of Medicare Part D on drug affordability and use: Are seniors with prior high out-of-pocket drug spending affected more?医疗保险处方药部分对药物可负担性和使用的影响:是否有先前高自付药物支出的老年人受到的影响更大?
Res Social Adm Pharm. 2010 Jun;6(2):90-9. doi: 10.1016/j.sapharm.2010.02.004.
5
Transition to Medicare Part D: an early snapshot of barriers experienced by younger dual eligibles with disabilities.向医疗保险D部分的过渡:年轻残疾双重资格者所经历障碍的早期概况。
Am J Manag Care. 2007 Jan;13(1):14-8.
6
Medicaid prescription drug utilization and expenditures following Part D.医疗补助计划(Medicaid)在D部分之后的处方药使用情况及支出
J Health Care Poor Underserved. 2010 May;21(2):715-28. doi: 10.1353/hpu.0.0278.
7
Medicare part D and changes in prescription drug use and cost burden: national estimates for the Medicare population, 2000 to 2007.医疗保险 D 部分与处方药使用和费用负担的变化:2000 年至 2007 年医疗保险人群的全国估计数。
Med Care. 2011 Sep;49(9):834-41. doi: 10.1097/MLR.0b013e3182162afb.
8
Impact of Medicare Part D on mental health treatment and outcomes for dual eligible beneficiaries with HIV.医疗保险D部分对双重资格的艾滋病毒受益人的心理健康治疗及结果的影响。
AIDS Care. 2019 Apr;31(4):505-512. doi: 10.1080/09540121.2018.1516283. Epub 2018 Sep 6.
9
Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D.医疗保险D部分实施前后青光眼弱势受益人群中处方药覆盖范围参保情况的变化
JAMA Ophthalmol. 2016 Feb;134(2):212-20. doi: 10.1001/jamaophthalmol.2015.5090.
10
The Medicare Part D doughnut hole: effect on pharmacy utilization.医疗保险D部分的药品福利缺口:对药房利用的影响。
Manag Care Interface. 2007 Sep;20(9):51-5, 59.

引用本文的文献

1
Racial and Ethnic Inequities in Managing Prescription Drug Costs Among Older Adults in Medicare.医疗保险中老年人处方药费用管理方面的种族和族裔不平等问题。
J Racial Ethn Health Disparities. 2025 Mar 3. doi: 10.1007/s40615-025-02329-5.
2
Estimating price elasticities of demand for pain relief drugs: evidence from Medicare Part D.估算止痛药物需求的价格弹性:来自医疗保险处方药部分的证据。
Int J Health Econ Manag. 2024 Dec;24(4):481-515. doi: 10.1007/s10754-024-09382-3. Epub 2024 Aug 2.
3
Pharmaceutical policies: effects of regulating drug insurance schemes.药品政策:规范药品保险计划的影响
Cochrane Database Syst Rev. 2022 May 3;5(5):CD011703. doi: 10.1002/14651858.CD011703.pub2.
4
Prevalence and Persistence of Cost-Related Medication Nonadherence Among Medicare Beneficiaries at High Risk of Hospitalization.住院高风险医疗保险受益人中与费用相关的药物治疗不依从的患病率和持续性
JAMA Netw Open. 2021 Mar 1;4(3):e210498. doi: 10.1001/jamanetworkopen.2021.0498.
5
The impact of Medicare part D prescription drug benefit program on generic drug prescription: A study in long-term care facilities.医疗保险D部分处方药福利计划对非专利药处方的影响:一项针对长期护理机构的研究。
Medicine (Baltimore). 2019 Aug;98(32):e16646. doi: 10.1097/MD.0000000000016646.
6
The impact of Medicare part D on income-related inequality in pharmaceutical expenditure.医疗保险 D 部分对药品支出与收入相关不平等的影响。
Int J Equity Health. 2019 Apr 16;18(1):57. doi: 10.1186/s12939-019-0955-9.
7
Impact of Medicare Part D on Racial and Ethnic Minorities.医疗保险处方药福利计划(Medicare Part D)对少数族裔的影响。
Divers Equal Health Care. 2016;13(5):326-333. Epub 2016 Aug 23.
8
Medicare Part D's Effects on Drug Utilization and Out-of-Pocket Costs: A Systematic Review.医疗保险D部分对药物使用和自付费用的影响:一项系统评价。
Health Serv Res. 2017 Oct;52(5):1685-1728. doi: 10.1111/1475-6773.12534. Epub 2016 Aug 1.
9
Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011.2005年与2011年美国老年人处方药、非处方药及膳食补充剂使用情况的变化
JAMA Intern Med. 2016 Apr;176(4):473-82. doi: 10.1001/jamainternmed.2015.8581.
10
Pharmaceutical policies: effects of cap and co-payment on rational use of medicines.药品政策:封顶价和共付额对合理用药的影响。
Cochrane Database Syst Rev. 2015 May 8;2015(5):CD007017. doi: 10.1002/14651858.CD007017.pub2.

本文引用的文献

1
The effect of transitioning to medicare part d drug coverage in seniors dually eligible for medicare and medicaid.同时符合医疗保险和医疗补助条件的老年人过渡到医疗保险D部分药物保险的影响。
J Am Geriatr Soc. 2008 Dec;56(12):2304-10. doi: 10.1111/j.1532-5415.2008.02025.x.
2
Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D.医疗保险D部分实施后与费用相关的药物治疗不依从性及基本需求支出
JAMA. 2008 Apr 23;299(16):1922-8. doi: 10.1001/jama.299.16.1922.
3
The impact of cost sharing on antidepressant use among older adults in British Columbia.费用分担对不列颠哥伦比亚省老年人抗抑郁药物使用的影响。
Psychiatr Serv. 2008 Apr;59(4):377-83. doi: 10.1176/ps.2008.59.4.377.
4
Should drug prices be negotiated under part D of Medicare? And if so, how?医疗保险D部分下的药品价格应该进行谈判吗?如果应该,该如何进行谈判?
Health Aff (Millwood). 2008 Jan-Feb;27(1):33-43. doi: 10.1377/hlthaff.27.1.33.
5
The effect of the Medicare Part D prescription benefit on drug utilization and expenditures.医疗保险D部分处方药福利对药物使用和支出的影响。
Ann Intern Med. 2008 Feb 5;148(3):169-77. doi: 10.7326/0003-4819-148-3-200802050-00200. Epub 2008 Jan 7.
6
Where are the Medicare Part D claims data?医疗保险D部分的理赔数据在哪里?
Ann Intern Med. 2008 Feb 5;148(3):239-40. doi: 10.7326/0003-4819-148-3-200802050-00202. Epub 2008 Jan 7.
7
The impact of Medicare Part D on prescription drug use by the elderly.医疗保险D部分对老年人处方药使用的影响。
Health Aff (Millwood). 2007 Nov-Dec;26(6):1735-44. doi: 10.1377/hlthaff.26.6.1735.
8
Medicare prescription drug benefit progress report: findings from a 2006 national survey of seniors.医疗保险处方药福利进展报告:2006年全国老年人调查结果
Health Aff (Millwood). 2007 Sep-Oct;26(5):w630-43. doi: 10.1377/hlthaff.26.5.w630. Epub 2007 Aug 21.
9
Medication access and continuity: the experiences of dual-eligible psychiatric patients during the first 4 months of the Medicare prescription drug benefit.药物获取与连续性:双重资格精神科患者在医疗保险处方药福利计划头四个月的经历
Am J Psychiatry. 2007 May;164(5):789-96. doi: 10.1176/ajp.2007.164.5.789.
10
Transition to Medicare Part D: an early snapshot of barriers experienced by younger dual eligibles with disabilities.向医疗保险D部分的过渡:年轻残疾双重资格者所经历障碍的早期概况。
Am J Manag Care. 2007 Jan;13(1):14-8.